Uguz, FarukSahingoz, Mine2024-02-232024-02-2320140362-56641537-162Xhttps://doi.org/10.1097/WNF.0000000000000036https://hdl.handle.net/20.500.12452/13592Depersonalization is a frequent symptom in depression and obsessive-compulsive disorder (OCD), but sometimes, it may be severe and concurrently diagnosed as a disorder. The treatment of depersonalization disorder both alone and comorbid with other psychiatric disorders is as yet unclear. This report presents the successful treatment with aripiprazole of concurrent depersonalization disorder in 3 patients with depression or OCD. The psychiatric disorders were diagnosed through structured clinical interviews. Assessments were by means of Yale-Brown Obsessive-Compulsive Scale, the Clinical Global Impression-Improvement Scale, and the 17-item Hamilton Rating Scale for Depression. Aripiprazole may be a beneficial psychotropic drug in the treatment of depersonalization disorder comorbid with OCD or depression, which is an important problem in clinical practice.eninfo:eu-repo/semantics/closedAccessAripiprazoleObsessive-Compulsive DisorderDepersonalizationDepressionReview Article374125127249920872-s2.0-84925379904Q3WOS:000339331500008Q310.1097/WNF.0000000000000036